April 25, 2025 7:19 PM

Latest:

Alberta Environment Minister Accuses Carney Of Disguising Climate Agenda As ‘Energy Superpower’ Push
Shipping Collapse Accelerates as Tariffs Trigger COVID-Level Disruption
India Suspends Trade with Pakistan Following Deadly Kashmir Attack
Hudson’s Bay to Shutter Remaining Stores as Liquidation Begins
Trump Slashes Energy & Mining Permitting Timelines Down To 28 Days

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

China’s CATL Announces Breakthrough EV Battery with 5-Minute Charging

Latest

Alberta Environment Minister Accuses Carney Of Disguising Climate Agenda As ‘Energy Superpower’ Push
Shipping Collapse Accelerates as Tariffs Trigger COVID-Level Disruption
India Suspends Trade with Pakistan Following Deadly Kashmir Attack
Hudson’s Bay to Shutter Remaining Stores as Liquidation Begins
Trump Slashes Energy & Mining Permitting Timelines Down To 28 Days
Trump Insists Trade Talks Underway, Beijing Firmly Denies
Carney Admits Trump Raised ’51st State’ Comments in March Call
Teck Resources See Q1 2025 Net Income Swing To $370M From Loss

Video

The $40 Billion Gold COMEX Delivery ‘Error’ That Wasn’t An Error | Peter Krauth

April 24, 2025 1:37 PM JP Alegre 0

In this timely interview, Peter Krauth from SilverStockInvestor.com provides a comprehensive analysis of the current precious metals landscape amid increasing

WeightWatchers Prepares For Bankruptcy Protection As It Loses Ground to Ozempic
BMO Ends Partnership with Cathie Wood's ARK Investment, Shutters Funds
Calibre Mining Sees Equinox Gold Lightly Sweeten Acquisition Terms Over Lack Of Support
Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
Newmont Sees Q1 2025 Net Income Surge Tenfold, Thanks To Soaring Gold Prices

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply